title: Free rein for drug ads? A slowdown in FDA review has left consumers more vulnerable to misleading messages.
mesh_terms: D000329:Advertising / Q000191:economics / Q000331:legislation & jurisprudence; D003257:Consumer Product Safety; D004345:Drug Industry / Q000331:legislation & jurisprudence; D011307:Drug Prescriptions; D005607:Fraud / Q000331:legislation & jurisprudence / Q000517:prevention & control; D005102:Health Expenditures; D006801:Humans; D007880:Legislation, Drug; D004364:Pharmaceutical Preparations; D010818:Practice Patterns, Physicians'; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D004364:Pharmaceutical Preparations